Stockreport

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

bioAffinity Technologies, Inc.  (BIAF) 
PDF Expanded CyPath® Lung test sales to physicians in Illinois, Alabama, and Louisiana; now receiving orders from physicians in 11 statesNumber of physician offices signed i [Read more]